ASTRO/SNMMI Joint Session: Unlocking Success in Radiopharmaceutical Therapy: Collaboration between Radiation Oncology, Nuclear Medicine and Industry
Theranostics, a treatment paradigm pairing diagnostic molecular imaging with radiopharmaceutical therapy (RPT), is resurgent, mainly driven by the FDA approvals of 177Lu-dotatate for neuroendocrine tumors and 177Lu-PSMA-617 for prostate cancer.
Category
- Radiopharmaceutical Therapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Precision in Practice: The Critical Role of Radiation Dosimetry in Radiotherapeutic Pharmaceuticals
Radiation dosimetry plays a critical role in the development and application of radiotherapeutic pharmaceuticals, ensuring both efficacy and safety in treatment.
Category
- Radiopharmaceutical Therapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Molecular Intelligence in Breast Cancer Radiation Therapy
Molecular testing is an integral component of multidisciplinary management of breast cancer. Recent evidence underscores the importance of molecular assays in radiation therapy decision making.
Category
- Breast
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Leveraging Anti-Tumor Immunity with Radiopharmaceutical Therapy (RPT) and Potential Combinatorial Approaches with RPT and Immunotherapy
Radiopharmaceutical Therapy (RPT) is an emerging modality with significant potential to impact future oncological management across many disease settings.
Category
- Radiopharmaceutical Therapy
- Immunotherapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Multidisciplinary Lung Cancer Tumor Board: A Case-Based Discussion Spanning Bread-and-Butter through the Gray Zone
The management of locally advanced lung cancer increasingly relies on multidisciplinary collaboration. Advances in neoadjuvant and perioperative chemoimmunotherapy have significantly improved outcomes for patients with resectable non-small cell lung cancer.
Category
- Thoracic
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Optimizing Sequencing in Immunotherapy and Radiotherapy for Non-Small Cell Lung Cancer – Clinical and Translational Advances
This combined immunotherapy track and lung cancer track brings together leading experts to discuss recent, cutting-edge trials and strategies in treating both locally advanced and metastatic non-small cell lung cancer (NSCLC). Dr.
Category
- Thoracic
- Immunotherapy
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $149.00
Management of Locally Recurrent Head and Neck Cancer
Locally recurrent HNSCC in the setting of prior radiation therapy is a challenging clinical scenario.
Category
- Head and Neck
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
ASTRO/ILROG Joint Activity: The Comeback of RT – Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas
Given the rarity of lymphomas, many clinicians are not using radiation therapy appropriately in the frontline setting.
Category
- Hematologic
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $149.00
Introductory Physics Modules
This course is designed to provide introductory physics videos and materials for radiation oncology residents.
Category
- Physics
Format
Credits
- 1.00 Certificate of Attendance
Cost $0.00
Exercise after a Cancer Diagnosis: From Research to Real Life
Exercise has been shown to improve numerous physical, psychosocial and clinical outcomes in those diagnosed with cancer.
Category
- Lifestyle Medicine
Format
- Sessions onDemand
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $49.00

Facebook
X
LinkedIn
Forward